Tesomet, a potential treatment for Prader-Willi syndrome (PWS), has been granted orphan drug status by the U.S. Food…
Articles by Forest Ray PhD
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
Through the end of the year, the Prader-Willi Syndrome Association USA (PWSA USA) is offering 24-hour family support services…
Daily treatment with diazoxide choline controlled release (DCCR) leads to sustained reductions in excessive appetite and other symptoms…
An online survey from Trinity College Dublin is seeking input from the parents and caregivers of young people with…
Lallemand Health Solutions has partnered with the Prader-Willi Syndrome Association (PWSA) to support Running for Research, an…
Inversago Pharma has obtained $35 million in financing to advance the development of therapies for disorders such as…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…
The Foundation for Prader-Willi Research (FPWR) is hosting a video competition to help spread awareness of Prader-Willi…
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the…